ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,201 Cr | ₹1,493 Cr | ₹2,609 Cr | ₹521 Cr | ₹283 Cr |
What is the latest Total Current Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,201 Cr |
| Mar2025 | ₹1,493 Cr |
| Mar2024 | ₹2,609 Cr |
| Mar2023 | ₹521 Cr |
| Mar2022 | ₹283 Cr |
How is Total Current Liabilities of ERIS LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,201 Cr | 47.46 | |
| Mar2025 | ₹1,493 Cr | -42.78 | |
| Mar2024 | ₹2,609 Cr | 400.58 | |
| Mar2023 | ₹521 Cr | 83.94 | |
| Mar2022 | ₹283 Cr | - | |
Compare Total Current Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹15,325.0 Cr | -1.9% | -13% | -31.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1.9% |
-13% |
-31.2% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses